(Press-News.org) RUSTON, La. – Physicists from Louisiana Tech University are part of an international team of researchers which has reported first results for the proton's weak charge based on precise new data from Jefferson Laboratory, the nation's premier electron beam facility for nuclear and particle physics research in Newport News, Va.
The results will be published in an upcoming issue of "Physical Review Letters," a prestigious and widely-referenced international journal that focuses on major advances in physics and cross disciplinary developments.
The "Q-weak" experiment used a high energy electron beam to measure the weak charge of the proton – a fundamental property that sets the scale of its interactions via the weak nuclear force. This is distinct from, but analogous to its more familiar electric charge (Q), hence the experiment's name: Q-weak. Following a decade of design and construction, Q-weak had a successful experimental run in 2010-12 at Jefferson Lab with data analysis having been underway ever since.
"This experiment establishes the equivalence between the electric force, which is responsible for a wide range of every day phenomenon from powering your microwave, to the structure of water and its impact on everyday life, and the weak force, both of which have a 'charge' which determines how well it interacts with, in this case, the proton, but to every other fundamental particle," said Dr. Steven Wells, associate professor of physics at Louisiana Tech and contributor to the Q-weak experiment.
In order to measure the proton's weak charge, experimenters had to exploit the weak interaction's unique property of parity violation, closely related to mirror symmetry. The Q-weak collaboration built an apparatus to detect the scattered electrons with unprecedented sensitivity, allowing them to measure the tiny asymmetry in the electron scattering rate that depends on the longitudinal polarization of the electron beam.
The success of the experiment relied on Jefferson Lab's world renowned "parity quality" beam properties. When the spin of the beam particles is reversed with respect to their direction of motion, the changes to its other properties are amazingly small, for example, the beam moves less than the width of an atom, on average.
"The future impacts of this potential discovery, should we find something outside the Standard Model, are huge," says Wells. "It could launch a big research effort, and attract students, teachers and others to seek answers to the big questions of the public such as 'Where are we from?' and 'Who are we?'"
According to the research team, to achieve the required statistical precision for Q-weak, the CEBAF accelerator at Jefferson Lab was pushed to new limits of high intensity polarized beam delivery, and the liquid hydrogen (proton) target built for Q-weak was able to absorb 1.7 kW of beam power while maintaining uniform density at a temperature of only 20 degrees above absolute zero, making it the world's highest power liquid hydrogen target to date.
"Nobody has ever attempted a measurement of the proton's weak charge before due to the extreme technical challenges to reach the required sensitivity," says Roger Carlini, Q-weak's spokesperson at Jefferson Lab. "The first four percent of the data have now been fully analyzed and already have an important scientific impact, although the ultimate sensitivity awaits analysis of the complete experiment."
Wells believes that Louisiana Tech's contributions to the experiment speak highly of the research taking place at the university.
"This is a world class institution at which we are preforming our research, and we have been involved in this experiment from the very beginning," Wells said. "In fact, Dr. Neven Simicevic designed the magnet and detectors of the experiment, and I designed many of the ancillary measurements necessary to minimize the uncertainty of the experiment, yet yielded interesting physics in their own right."
The Q-weak experiment and its findings were achieved by a team of 97 researchers from 23 institutions in the US, Canada, and Europe. It was made possible by funding from the US Department of Energy and National Science Foundation, the Natural Sciences and Engineering Research Council of Canada, university matching contributions from The College of William and Mary, Virginia Tech, George Washington University, and Louisiana Tech University, and technical and engineering support from Jefferson Lab as well as TRIUMF (Canada) and MIT-Bates laboratories.
###
Louisiana Tech University physicists contribute to new findings of international research team
2013-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Three hours is enough to help prevent mental health issues in teens
2013-10-03
This news release is available in French. The incidence of mental health issues amongst 509 British youth was reduced by 25 to 33% over the 24 months following two 90-minute group therapy sessions, according to a study led by Dr. Patricia Conrod of the University of Montreal and its affiliated Sainte-Justine Hospital Research Centre. "Almost one-in-four American 8 to 15 year olds has experienced a mental health disorder over the past year. We know that these disorders are associated with a plethora of negative consequences," Conrod said. "Our study shows that teacher ...
Drowsy Drosophila shed light on sleep and hunger
2013-10-03
Why does hunger keep us awake and a full belly make us tired? Why do people with sleep disorders such as insomnia often binge eat late at night? What can sleep patterns tell us about obesity?
Sleep, hunger and metabolism are closely related, but scientists are still struggling to understand how they interact. Now, Brandeis University researchers have discovered a function in a molecule in fruit flies that may provide insight into the complicated relationship between sleep and food.
In the October issue of the journal Neuron, Brandeis scientists report that sNPF, a ...
New small-molecule catalyst does the work of many enzymes
2013-10-03
CHAMPAIGN, Ill. — Researchers report that they have created a man-made catalyst that is an "enzyme mimic." Unlike most enzymes, which act on a single target, the new catalyst can alter the chemical profiles of numerous types of small molecules. The catalyst – and others like it – will greatly speed the process of drug discovery, the researchers say.
Their findings appear in the Journal of the American Chemistry Society.
Most enzymes are large proteins that act on only one molecular target, said University of Illinois chemistry professor M. Christina White, who conducted ...
How depression blurs memories
2013-10-03
To pinpoint why depression messes with memory, researchers took a page from Sesame Street's book.
The show's popular game "One of these things is not like the others" helps young viewers learn to differentiate things that are similar – a process known as "pattern separation."
A new Brigham Young University study concludes that this same skill fades in adults in proportion to the severity of their symptoms of depression. The more depressed someone feels, the harder it is for them to distinguish similar experiences they've had.
If you've ever forgotten where you parked ...
3D dynamic imaging of soft materials
2013-10-03
Autumn is usually not such a great time for big special effects movies as the summer blockbusters have faded and those for the holiday season have not yet opened. Fall is more often the time for thoughtful films about small subjects, which makes it perfect for the unveiling of a new movie produced by researchers at the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab). Through a combination of transmission electron microscopy (TEM) and their own unique graphene liquid cell, the researchers have recorded the three-dimensional motion of ...
Innovative approach could ultimately end deadly disease of sleeping sickness
2013-10-03
CORVALLIS, Ore. – A tag team of two bacteria, one of them genetically modified, has a good chance to reduce or even eliminate the deadly disease African trypanosomiasis, or sleeping sickness, researchers at Oregon State University conclude in a recent mathematical modeling study.
African trypanosomiasis, caused by a parasite carried by the tsetse fly, infects 30,000 people in sub-Saharan Africa each year and is almost always fatal without treatment. In a 2008 epidemic, 48,000 people died.
In this research, scientists evaluated the potential for success of a new approach ...
New study suggests changing bacterial mix may lead to painful sex after menopause
2013-10-03
CLEVELAND, Ohio (October 3, 2013) -- The mix of bacteria in the vagina changes as women go through menopause. And a certain mix is typical after menopause in women who have vulvovaginal atrophy (VVA), a common cause of vaginal dryness and sexual pain, finds a team at Johns Hopkins and the University of Maryland. They suspect these bacteria may play a role in causing VVA and that personalized probiotics or other ways to manage the bacterial mix might prevent or treat VVA in the future. Their study was published online today in Menopause, the journal of The North American ...
Health of honey bees adversely impacted by selenium
2013-10-03
RIVERSIDE, Calif. — Traditionally, honey bee research has focused on environmental stressors such as pesticides, pathogens and diseases. Now a research team led by entomologists at the University of California, Riverside has published a study that focuses on an anthropogenic pollutant: selenium (Se).
The researchers found that the four main forms of Se in plants — selenate, selenite, methylselenocysteine and selenocystine — cause mortality and delays in development in the honey bee.
"Metal pollutants like selenium contaminate soil, water, can be accumulated in plants, ...
Researchers unveil method for creating 're-specified' stem cells for disease modeling
2013-10-03
Boston, Mass., Oct. 3, 2013 – In a paper in Cell Stem Cell, a team led by researchers in the Boston Children's Hospital's Stem Cell Transplantation Program reports a new approach for turning induced pluripotent stem cells (iPSCs) into hematopoietic stem and progenitor cells for in vivo disease modeling.
With this strategy—which they call re-specification—the team, including Sergei Doulatov, PhD, and George Daley, MD, PhD, of Boston Children's, may have overcome technical barriers to generating blood disease-specific animal models from the thousands of iPSC cell lines ...
Old remedy shows promise as new chemo drug for bladder cancer
2013-10-03
MAYWOOD, Il. – An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer.
Years ago, ipecac syrup was used to induce vomiting in poisoning cases. Now a Loyola University Medical Center study has found that the active ingredient of ipecac syrup effectively inhibits the growth of bladder cancer cells, especially when combined with a standard chemotherapy drug.
The study by corresponding authors Kimberly Foreman, PhD, Gopal Gupta, MD, and colleagues is published ...